ConductScience.org, home

Paper29697201

Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.

Wang X and 1 other. Thorac Cancer, 2018. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53. Papers, record 29697201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29697201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
PubMed
Journal
Thorac Cancer
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2019-12-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XXinyanhttps://orcid.org/0000-0002-4126-231X
2Zhu JJianweihttps://orcid.org/0000-0002-1087-5543

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
CisplatinMajor topic
Drug Resistance, NeoplasmMajor topic
MicroRNAsMajor topic
Nuclear ProteinsMajor topic
Proto-Oncogene ProteinsMajor topic
Cell Cycle Proteins
Cell Line, Tumor
Female
Gene Expression Regulation, Neoplastic
Humans
MCF-7 Cells
Tumor Suppressor Protein p53

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116518375Targeting multidrug resistance in cancer.Nat Rev Drug Discov2006https://conductscience.org/library/papers/16518375PubMed
225717219Cancer statistics: updated cancer burden in China.Chin J Cancer Res2015https://conductscience.org/library/papers/25717219PubMed
323893241miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.Oncogene2014https://conductscience.org/library/papers/23893241PubMed
49703789Chemotherapy resistance in breast cancer.Anticancer Res1998https://conductscience.org/library/papers/9703789PubMed
58895579MDMX: a novel p53-binding protein with some functional properties of MDM2.EMBO J1996https://conductscience.org/library/papers/8895579PubMed
620162574miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.Int J Cancer2010https://conductscience.org/library/papers/20162574PubMed
712154352Live or let die: the cell's response to p53.Nat Rev Cancer2002https://conductscience.org/library/papers/12154352PubMed
812545155A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.Oncogene2003https://conductscience.org/library/papers/12545155PubMed
925651787Global cancer statistics, 2012.CA Cancer J Clin2015https://conductscience.org/library/papers/25651787PubMed
1014744438MicroRNAs: genomics, biogenesis, mechanism, and function.Cell2004https://conductscience.org/library/papers/14744438PubMed
1125674237High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/25674237PubMed
1216141061Ribo-gnome: the big world of small RNAs.Science2005https://conductscience.org/library/papers/16141061PubMed
1323178712miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.FEBS Lett2013https://conductscience.org/library/papers/23178712PubMed
1424144591miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.Biochem Biophys Res Commun2013https://conductscience.org/library/papers/24144591PubMed
1528086946MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.J Ovarian Res2017https://conductscience.org/library/papers/28086946PubMed
1611902585Multidrug resistance in cancer: role of ATP-dependent transporters.Nat Rev Cancer2002https://conductscience.org/library/papers/11902585PubMed
1711099028Surfing the p53 network.Nature2000https://conductscience.org/library/papers/11099028PubMed
1816918307Biomarkers and multiple drug resistance in breast cancer.Curr Cancer Drug Targets2006https://conductscience.org/library/papers/16918307PubMed
1927362808miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.Cell Death Dis2016https://conductscience.org/library/papers/27362808PubMed
2021471222Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer.J Biol Chem2011https://conductscience.org/library/papers/21471222PubMed

See all 22 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42802834Reduced Exosomal miR-22 Promotes Cisplatin Resistance and Migration in Non-Small Cell Lung Cancer Cells Through MDM4 Upregulation.Onco Targets Ther2026https://conductscience.org/library/papers/42802834PubMed
39849498Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and affects breast cancer aggressiveness.BMC Biol2025https://conductscience.org/library/papers/39849498PubMed
39382427MicroRNA-1307-3p contributes to breast cancer progression through PRM2.Thorac Cancer2024https://conductscience.org/library/papers/39382427PubMed
35559394LncRNA TTN-AS1 confers tamoxifen resistance in breast cancer via sponging miR-107 to modulate PI3K/AKT signaling pathway.Am J Transl Res2022https://conductscience.org/library/papers/35559394PubMed
35456388MicroRNA Expression in Pseudoexfoliation Syndrome with the Use of Next-Generation Sequencing.Genes (Basel)2022https://conductscience.org/library/papers/35456388PubMed
35444536Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review.Front Pharmacol2022https://conductscience.org/library/papers/35444536PubMed
35018230MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.Am J Cancer Res2021https://conductscience.org/library/papers/35018230PubMed
34767243MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.Reprod Sci2022https://conductscience.org/library/papers/34767243PubMed
34524579MicroRNAs as a clue to overcome breast cancer treatment resistance.Cancer Metastasis Rev2022https://conductscience.org/library/papers/34524579PubMed
33888565The roles and regulation of MDM2 and MDMX: it is not just about p53.Genes Dev2021https://conductscience.org/library/papers/33888565PubMed
33569931Breast Ultrasound Microvascular Imaging and Radiogenomics.Korean J Radiol2021https://conductscience.org/library/papers/33569931PubMed
33507700Association between Genetic Polymorphisms of miR-1307, miR- 1269, miR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/33507700PubMed
33084878Pyntacle: a parallel computing-enabled framework for large-scale network biology analysis.Gigascience2020https://conductscience.org/library/papers/33084878PubMed
33014864Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.Front Oncol2020https://conductscience.org/library/papers/33014864PubMed
32811812The rs7911488-T allele promotes the growth and metastasis of colorectal cancer through modulating miR-1307/PRRX1.Cell Death Dis2020https://conductscience.org/library/papers/32811812PubMed
32635183Identification of miRNA Master Regulators in Breast Cancer.Cells2020https://conductscience.org/library/papers/32635183PubMed
32309220Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis.Iran J Public Health2020https://conductscience.org/library/papers/32309220PubMed
31841993Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/31841993PubMed
31402562miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.Mol Oncol2019https://conductscience.org/library/papers/31402562PubMed
30689920The long and the short of it: the MDM4 tail so far.J Mol Cell Biol2019https://conductscience.org/library/papers/30689920PubMed

Download CSV of cited by

Genes21

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CDC42998PubTator's text mininghttps://conductscience.org/library/genes/998NCBI Gene
CDK61021PubTator's text mininghttps://conductscience.org/library/genes/1021NCBI Gene
ING584289PubTator's text mininghttps://conductscience.org/library/genes/84289NCBI Gene
MDM44194PubTator's text mininghttps://conductscience.org/library/genes/4194NCBI Gene
MIR1307100302174PubTator's text mininghttps://conductscience.org/library/genes/100302174NCBI Gene
MIR137406928PubTator's text mininghttps://conductscience.org/library/genes/406928NCBI Gene
MIR141406933PubTator's text mininghttps://conductscience.org/library/genes/406933NCBI Gene
MIR148B442892PubTator's text mininghttps://conductscience.org/library/genes/442892NCBI Gene
MIR21406991PubTator's text mininghttps://conductscience.org/library/genes/406991NCBI Gene
MIR222407007PubTator's text mininghttps://conductscience.org/library/genes/407007NCBI Gene
MIR26A1407015PubTator's text mininghttps://conductscience.org/library/genes/407015NCBI Gene
MIR302D442896PubTator's text mininghttps://conductscience.org/library/genes/442896NCBI Gene
MIR451A574411PubTator's text mininghttps://conductscience.org/library/genes/574411NCBI Gene
MIR486-1619554PubTator's text mininghttps://conductscience.org/library/genes/619554NCBI Gene
MIR491574444PubTator's text mininghttps://conductscience.org/library/genes/574444NCBI Gene
MIR503574506PubTator's text mininghttps://conductscience.org/library/genes/574506NCBI Gene
MIR611693196PubTator's text mininghttps://conductscience.org/library/genes/693196NCBI Gene
MTDH92140PubTator's text mininghttps://conductscience.org/library/genes/92140NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene

See all 21 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29697201

GET https://conductscience.org/api/papers/v1/29697201/references?page=2